It can be concluded from this study that serum sCD40L levels in SS patients persistently increased significantly in the first 3 days after admission to the intensive care unit, and circulating sCD40L levels were increased on the second day of admission in the nonsurviving group compared with the surviving group. This evidence concerns the gene CD40LG and synovial sarcoma.